Published January 28, 2018
| Version v1
Dataset
Open
Western Blotting NSD3 in AML Cell Lines
Description
SGC Open Lab Notebook Project - Understanding the Role of NSD3 in Cancer
Experiment 011 - Western blot of MOLM-13, UCSD-AML1, and HL-60 AML cell lines probing for NSD3.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
2018-01-24-Western-Blotting-NSD3-in-AML-Cell-Lines_DDilworth.pdf
Files
(497.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:137a096a273a4a013edd199609b42f2a
|
497.6 kB | Preview Download |